CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase III Double-Blind Study Of Depot Octreotide Versus Placebo In The Prevention Of Acute Diarrhea In Patients Receiving Pelvic Radiation Therapy
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00033605
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:10.604952+00:00
- Published At
- 2016-07-13T00:00:00+00:00
- Record Updated At
- 2016-07-13
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Cervical Cancer", "Colorectal Cancer", "Diarrhea", "Endometrial Cancer", "Fallopian Tube Cancer", "Ovarian Cancer", "Prostate Cancer", "Sarcoma", "Unspecified Adult Solid Tumor, Protocol Specific", "Vaginal Cancer", "Vulvar Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-07-13"- protocolSection.identificationModule.nctId
"NCT00033605"- protocolSection.identificationModule.officialTitle
"Phase III Double-Blind Study Of Depot Octreotide Versus Placebo In The Prevention Of Acute Diarrhea In Patients Receiving Pelvic Radiation Therapy"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.